Highlights
1 patent
About
Treatments for Binge Behavior and Mental Health
Clearmind Medicine develops treatments for binge behavior and mental health, including alcohol use disorder, binge eating and depression. Clearmind develops MEAI that exerts a euphoric alcohol-like experience and a reduced desire to consume alcoholic beverages with potential to change the lives of millions who struggle to drink in moderation.
Identity
| Name | Clearmind Medicine |
|---|---|
| Slug | clearmind-medicine |
| Type / kind | startup |
| Crunchbase ID | clearmind-medicine |
| Source _id | Pj6N1R3SA9L85cnZOzKPiwJWxCTETzzRjK977NJYreLKDEmOg9HSBM |
Status
| Status | active |
|---|---|
| Status reason | Public on CSE on Jun 2022;Public on NASDAQ on Nov 2022; |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ city | Tel Aviv-Yafo |
| HQ address | Raoul Wallenberg St 20, Tel Aviv-Yafo, Israel |
Web & social
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcareLaboratories
Business models
B2B
Tags
drug-discoverymental-healthpharmaceuticals
Funding
| Total raised | $16.2M |
|---|---|
| Current stage | Public |
| Market cap | $2.2M |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}